Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
120
currently held
Exits tracked
78
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin167 companies matching · Page 3 of 4
MEDEA Biopharma
Caesar Ventures Fund I
Sector
Biotech
InvestorCaesar Ventures Management
Entry
2024
Hold
2yr
multimmune
S-Refit AG
Sector
Biotech
InvestorSobera Capital
Entry
2016
Hold
10yr
Nostos Genomics
42CAP II
Sector
Biotech
Investor42CAP
Entry
2022
Hold
4yr
OMEICOS
HTGF II
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2013
Hold
13yr
Omeicos Therapeutics
VC Fonds Technologie Berlin
Sector
Biotech
InvestorIBB Ventures
Entry
2014
Hold
12yr
Palveera
HTGF III
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
PAM Theragnostics GmbH
Fruehphasen- und Wachstumsfonds Brandenburg
Sector
Biotech
InvestorBrandenburg Kapital
Entry
2021
Hold
5yr
PerioTrap Pharmaceuticals
IBG Innovationsfonds
Sector
Biotech
Investorbmp Ventures AG
Entry
2020
Hold
6yr
Pheiron
Ananda Impact Fund IV
Sector
Biotech
InvestorAnanda Impact Ventures
Entry
2025
Hold
1yr
Phialogics
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2022
Hold
4yr
PlasmidFactory
MED III
Sector
Biotech
InvestorARCHIMED
Entry
2022
Hold
4yr
PRIMACYT Cell Culture Technology GmbH
Technologiefonds Mecklenburg-Vorpommern
Sector
Biotech
InvestorGENIUS Venture Capital
Entry
2004
Hold
22yr
Prosion
Freigeist Deep-Tech Evergreen
Sector
Biotech
InvestorFreigeist Capital
Entry
2022
Hold
4yr
Provirex
Bioventure Club Deals
Sector
Biotech
InvestorBioventure Management
Entry
2022
Hold
4yr
Provolut
Atlantic Labs I
Sector
Biotech
InvestorAtlantic Labs
Entry
2025
Hold
1yr
Repairon
Bioventure Club Deals
Sector
Biotech
InvestorBioventure Management
Entry
2025
Hold
1yr
Resolve Biosciences
HTGF III
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2020
Hold
6yr
Seamless Therapeutics
Wellington Partners Life Sciences
Sector
Biotech
InvestorWellington Partners
Entry
2023
Hold
3yr
SIRS Therapeutics
Wellington Partners Life Sciences
Sector
Biotech
InvestorWellington Partners
Entry
2020
Hold
6yr
SMIN Therapeutics GmbH
Technologiefonds Hessen
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2023
Hold
3yr
SRTD biotech
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
StratifAI
Heliad Evergreen Holdings
Sector
Biotech
InvestorHeliad AG
Entry
2025
Hold
1yr
T-Knife
BioDiscovery 5
Sector
Biotech
InvestorAndera Partners
Entry
2018
Hold
8yr
TolerogenixX
HTGF II
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
TQ Therapeutics
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
VEROVACCiNES
HTGF III
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Vivalyx
TechVision Fonds I
Sector
Biotech
InvestorS-UBG AG Aachen Krefeld Mönchengladbach
Entry
2024
Hold
2yr
Vivoryon Therapeutics
bmp Aktiengesellschaft
Sector
Biotech
Investorbmp Ventures AG
Entry
1997
Hold
29yr
Zedira
HTGF I
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2007
Hold
19yr
Insempra
Possible Ventures Fund III
Sector
Biotech
InvestorPossible Ventures
Entry
2020
Hold
6yr
Owners
5
Abalos Therapeutics
coparion
Sector
Biotech
Investorcoparion
Entry
2019
Hold
7yr
Owners
4
SenseUp
Simon Capital Evergreen
Sector
Biotech
InvestorSimon Capital
Entry
2025
Hold
1yr
Owners
4
AmSilk
Athos Evergreen Life Sciences
Sector
Biotech
InvestorAthos
Entry
2008
Hold
18yr
Owners
3
DISCO Pharmaceuticals
NRW.Venture
Sector
Biotech
InvestorNRW.BANK
Entry
2023
Hold
3yr
Owners
3
Pacifico Biolabs
Simon Capital Evergreen
Sector
Biotech
InvestorSimon Capital
Entry
2024
Hold
2yr
Owners
3
Ariceum Therapeutics
Earlybird Health
Sector
Biotech
InvestorEarlybird Venture Capital
Entry
2022
Hold
4yr
Owners
2
Booster Therapeutics
Apollo Health Ventures Fund II
Sector
Biotech
InvestorApollo Health Ventures
Entry
2024
Hold
2yr
Owners
2
Cambrium
Redstone Ventures
Sector
Biotech
InvestorRedstone
Entry
2020
Hold
6yr
Owners
2
Captain T Cell GmbH
Technologiegründerfonds Sachsen
Sector
Biotech
InvestorCFH Management
Entry
2024
Hold
2yr
Owners
2
COLIPI
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
Owners
2
CPTx
BlueYard Capital Fund III
Sector
Biotech
InvestorBlueYard Capital
Entry
2024
Hold
2yr
Owners
2
iDEL Therapeutics
Gruenderfonds Ruhr II
Sector
Biotech
InvestorGruenderfonds Ruhr
Entry
2025
Hold
1yr
Owners
2
2NA FISH
GF BRYCK Ventures
Sector
Biotech
InvestorGruenderfonds Ruhr
Entry
2026
Hold
0yr
advanceCOR
MIG Fonds 5
Sector
Biotech
InvestorMIG Capital
Entry
2012
Hold
14yr
Allecra
BioDiscovery 4
Sector
Biotech
InvestorAndera Partners
Entry
2013
Hold
13yr
Apogenix
dievini Hopp BioTech holding (Evergreen Balance Sheet)
Sector
Biotech
Investordievini Hopp BioTech holding
Entry
2005
Hold
21yr
Ariceum Therapeutics GmbH
Seed and Venture Capital Scheme 2019-2024
Sector
Biotech
InvestorEnterprise Ireland
Entry
–
ASTRA Therapeutics
MIG Fonds 17
Sector
Biotech
InvestorMIG Capital
Entry
2025
Hold
1yr
AyoxxA
NRW.Venture
Sector
Biotech
InvestorNRW.BANK
Entry
2012
Hold
14yr
baseclick
ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen)
Sector
Biotech
InvestorD11Z. Ventures
Entry
2020
Hold
6yr